Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Journal of Gastrointestinal Cancer
Published in: Journal of Gastrointestinal Cancer 1/2014

01-03-2014 | Case Report

Esophageal Cancer and Dysphagia in the HIV-Positive Patient

Authors: Thomas D. Willson, Arsalan Salamat, Tracy E. Sambo, Mark M. Connolly, Francis J. Podbielski

Published in: Journal of Gastrointestinal Cancer | Issue 1/2014

Login to get access

Excerpt

Over the past 30 years, improvements in management and heightened awareness have contributed to increased survival among HIV-positive patients and the conversion of the disease from an acute, fulminant illness into a chronic condition [1, 2]. Mortality from end-stage AIDS or from HIV-related illnesses has precipitously decreased. In fact, recent data suggest that the 6-month cumulative mortality from a serious, non-AIDS event is more than twice the mortality for an AIDS event in HIV-positive patients [3]. This suggests the need for vigilance on the part of clinicians for serious events unrelated to a coexisting diagnosis of HIV/AIDS. …
Literature
1.
Palella Jr FJ, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT. Holmberg SD; HIV Outpatient Study Investigators. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43(1):27–34.PubMedCrossRef
2.
Issa RA, Podbielski FJ, Fontaine JP, Connolly AE, Walsh WV, Fraire AE. Esophagectomy in a patient with AIDS. Diseases of the Esophagus. 2004;17(3):270–2.PubMedCrossRef
3.
Neuhaus J, Angus B, Kowalska JD, La Rosa A, Sampson J, Wentworth D, et al. INSIGHT SMART and ESPIRIT study groups. Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV. AIDS. 2010;24(5):697–706.PubMedCentralPubMedCrossRef
4.
Wilcox CM. Esophageal disease in the acquired immunodeficiency syndrome: etiology, diagnosis, and management. Am J Med. 1992;92(4):412–21.PubMedCrossRef
5.
6.
Bobba RK, El-Dika SS, Arsura EL. Dysphagia in a HIV patient: concern for the etiology? Southern Medical Journal. 2007;100(1):61–2.PubMedCrossRef
7.
Stebbing J, Krown SE, Bower M, Batra A, Slater S, Serraino D, et al. Primary esophageal carcinoma in the era of highly active antiretroviral therapy. Arch Intern Med. 2010;170(2):203–7.PubMedCrossRef
8.
Persson EC, Shiels MS, Dawsey SM, Bhatia K, Anderson LA, Engels EA. Increased risk of stomach and esophageal malignancies in people with AIDS. Gastroenterology. 2012;143(4):943–50.PubMedCrossRef
9.
Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer. 2008;123(1):187–94.PubMedCrossRef
10.
Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, et al. for the HIV/AIDS Cancer Match Study. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS. 2006;20(12):1645–54.PubMedCrossRef
11.
Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370:59–67.PubMedCrossRef
12.
Reekie J, Kowalska D, Karpov I, Rockstroh J, Karlsson A, Rakhmanova A, et al. EuroSIDA in EuroCoord. Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study. PLoS One. 2012;7(7):e41673.PubMedCentralPubMedCrossRef
13.
Lewden C, Salmon D, Morlat P, Bevilacqua S, Jougla E, Bonnet F, et al. Mortality 2000 study group. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. International Journal of Epidemiology. 2005;34(1):121–30.PubMedCrossRef
14.
Reinhold JP, Moon M, Tenner CT, Poles MA, Bini EJ. Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention. Am J Gastroenterol. 2005;100(8):1805–12.PubMedCrossRef
15.
Metadata
Title
Esophageal Cancer and Dysphagia in the HIV-Positive Patient
Authors
Thomas D. Willson
Arsalan Salamat
Tracy E. Sambo
Mark M. Connolly
Francis J. Podbielski
Publication date
01-03-2014
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 1/2014
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-013-9487-5

Other articles of this Issue 1/2014

Journal of Gastrointestinal Cancer 1/2014 Go to the issue

Case Report

Extra-skeletal Osteosarcoma Presenting as a Peri-ampullary Mass

Letter to the Editor

Diffuse Gastroduodenal Metastasis from Cutaneous Malignant Melanoma Presenting as Amelanotic “Volcano-Like” Ulcers

Original Research

Three-Field Transthoracic Versus Transhiatal Esophagectomy in the Management of Carcinoma Esophagus—a Single-Center Experience with a Review of Literature

Original Research

Clinical Outcomes of Stenting for Colorectal Obstruction at a Tertiary Centre

Review Article

The Role of Cirrhosis in the Etiology of Hepatocellular Carcinoma

Original Research

Efficacy of Endoscopic Submucosal Dissection for Cancer of the Operated Stomach
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits